This webinar is part of a three-part heart failure focussed cardiology webinar series. This webinar will cover the following learning objectives:
- Outline the burden of heart failure in Australia
- Review the outcomes of landmark trials leading to use of SGLT2 inhibitors in patients with heart failure
- Briefly explain practical considerations, including dosing, adverse effects, monitoring and precautions, of using SGLT2 inhibitors in patients with heart failure
- Briefly review the impact of other diabetic therapies on heart failure
- Overview emerging evidence for other heart failure treatments